Navigation Links
FDA approves new device to treat women's bleeding disorder

The government has approved a new method to treat women suffering excessive menstrual bleeding, a device that uses radio waves to zap the tissue at fault. Millions of women suffer menorrhagia, benign but troubling menstrual bleeding so excessive they can require more than 20 tampons in a single day. Thousands of women every year get hysterectomies to cure menorrhagia, while other women try hormone treatment.//

The other option is to destroy part of the lining of the uterus, called the endometrium. Gynecologists can scrape off part of the endometrium, much as they do during abortion, or can use one of a handful of outpatient FDA-approved devices that destroy the endometrium by freezing or heating it.

The Food and Drug Administration approved Novacept Inc.'s NovaSure system as an outpatient electronic treatment for women hoping to cure the bleeding without a hysterectomy. NovaSure is the first of those outpatient options that heats the endometrium using radio-frequency energy. The company said it will begin selling the devices to gynecologists in mid-November.


'"/>




Page: 1

Related medicine news :

1. FDA approves surgical gel
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Alerts for safety of heart device
Post Your Comments:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...ny doctors of Indian origin live in a state of pen...emples. Very few of them even have decent // lodg...e NHS for more doctors to serve in the country in ...rs from third world countries migrating to the UK....
Indonesia Claims To Have Arrested The Bird Flu.
...ndon: What has been known to us all is now proven ...est medicine according to a report published in cu...hich explains how laughter has evolved over the pa...re are two types of laughter – genuine and artific...
Study Reveals Better Results in Patients Suffering From Depression.
Other Medicine News:Health News:Genuine Laughter Is The Best Medicine! 2Health News:Study Reveals Better Results in Patients Suffering From Depression. 2
(Date:7/22/2008)...R) Resulted in Significant, Reductions in A1C in P...hm Used, BRIDGEW...he "Adjust to,Target in Type 2 Diabetes: Compariso...or Adjustment of Mealtime Insulin Glulisine" study...ion,s (ADA) medical journal,Diabetes Care. This s...
(Date:7/22/2008)...sity Medical Center Based on Rosetta Gen... Differentiates Squamous From Non-Squamous Non-Sma...-Cell Carcinoma of the Lung With Sensitivit... is the First CLIA Approved Test Which Leverages M...ccurate Diagnosis of Lung Cancer, REHOVOT, Israel...
(Date:7/22/2008)...ach of LASH (Laser Assisted Scar Healing) can ...EILLES, France, July 22 /- Ekkyo (for...e company, which develops first-in-class,laser-bas... announced today,the publication of a scientific a...g the results of a pilot study on cutaneous scar p...
(Date:7/21/2008)...imvastatin and Ezetimibe in,Aortic Stenosis) study...erol lowering with the combination of simvastatin ...nts with aortic stenosis., Aortic stenosis (which...the heart) is a relatively common disease among ol... it can progress to death from heart failure or,ca...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Japanese and German researchers meet to discuss climate change 1905 1Japanese and German researchers meet to discuss climate change 1905 2Japanese and German researchers meet to discuss climate change 1905 3Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 1Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 2Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 3Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store 9557 1Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store 9557 2Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 1Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 2Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 3
...or Growth, Data Suggest, DURHAM, N.C., April 30, 2... research group from Northern Ireland cautions aga...d,"erythropoiesis-stimulating agents" (ESAs) to tr... commentary in the April issue of,The Oncologist, ...Terence R. Lappin and colleagues of Queen,s,Univer...
...rnal of the National Cancer,Institute , , , ...udy published today in,the Journal of the National...hera was shown to improve overall survival in pati...regimen used.1 The,review further stated that the ...e in patients with mantle cell lymphoma, a rare,a...
Other Medicine Technology:Researchers Urge Caution in Using ESAs for Cancer-Related Anemia 2Researchers Urge Caution in Using ESAs for Cancer-Related Anemia 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4
...re Platinum XL Concentrator offers all the great f...elp lower lifecycle costs. Platinum XL features an... preventative maintenance is required by 40%! Plat... now a full 5 years with no hour limit on the comp...
Introducing the new Platinum 10 concentrator. The Platinum 10 delivers the reliability, performance and value advantage you have come to expect from the Platinum line of concentrators and provides an
...ifeStyle Portable Oxygen Concentrator is the most ...re. At less than 10 lbs (4.5 kg), this unit was de...highly active oxygen patient., ,Operating as ...s of both an oxygen concentrator and an oxygen con...
OCD-3000 pnuematic conserving regulator.
Medicine Products: